comparemela.com

Page 5 - James Peyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

From the DealBook Summit: Leaders Look Into the Future

Cambrian Biopharma CEO James Peyer Named 2022 BioTech Company CEO of the Year By BioTech Breakthrough

Biotechnology Innovators Honored in 2022 BioTech Breakthrough Awards Program

Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular

- Fundraising led by Cambrian BioPharma and Solve FSHD Company expands pipeline with new program, VTA-120, for the treatment of facioscapulohumeral muscular dystrophy (FSHD) -BALTIMORE (BUSINESS WIRE) Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therap.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.